Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

SGMOQ holding history

Sangamo Therapeutics, Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of SGMOQ by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,836,665−100.0%Sold outHolders
Q1 20263,836,665$947.3K<0.1%−4,593,658−54.5%ReducedHolders
Q4 20258,430,323$3.54M<0.1%−1,752,140−17.2%ReducedHolders
Q3 202510,182,463$6.86M<0.1%+3,343,029+48.9%AddedHolders
Q2 20256,839,434$3.70M<0.1%+3,671,327+115.9%AddedHolders
Q1 20253,168,107$2.08M<0.1%+83,230+2.7%AddedHolders
Q4 20243,084,877$3.15M<0.1%−1,767,900−36.4%ReducedHolders
Q3 20244,852,777$4.20M<0.1%+726,200+17.6%AddedHolders
Q2 20244,126,577$1.48M<0.1%+1,528,600+58.8%AddedHolders
Q1 20242,597,977$1.74M<0.1%−547,901−17.4%ReducedHolders
Q4 20233,145,878$1.71M<0.1%+780,124+33.0%AddedHolders
Q3 20232,365,754$1.42M<0.1%−701,742−22.9%ReducedHolders
Q2 20233,067,496$3.99M<0.1%−165,299−5.1%ReducedHolders
Q1 20233,232,795$5.69M<0.1%+1,113,299+52.5%AddedHolders
Q4 20222,119,496$6.66M<0.1%+453,400+27.2%AddedHolders
Q3 20221,666,096$8.16M<0.1%+226,600+15.7%AddedHolders
Q2 20221,439,496$5.96M<0.1%+676,400+88.6%AddedHolders
Q1 2022763,096$4.43M<0.1%−87,600−10.3%ReducedHolders
Q4 2021850,696$6.38M<0.1%+115,196+15.7%AddedHolders
Q3 2021735,500$6.63M<0.1%+152,300+26.1%AddedHolders
Q2 2021583,200$6.98M<0.1%−196,600−25.2%ReducedHolders
Q1 2021779,800$9.77M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.